Abstract

We characterize novel breast cancer imaging biomarkers for monitoring neoadjuvant chemotherapy (NACT) and predicting outcome. Specifically, we recruited 30 patients for a pilot study in which NACT patients were imaged using dynamic tomographic optical breast imaging (DTOBI) to quantify the hemodynamic changes due to partial mammographic compression. DTOBI scans were obtained pre-treatment (referred to as day 0), as well as 7 and 30 days into therapy on female patients undergoing NACT. We present data for the 13 patients who participated in both day 0 and 7 measurements and had evaluable data, of which 7 also returned for day 30 measurements. We acquired optical images over 2 minutes following 4-8 lbs (18-36 N) of compression. The timecourses of tissue-volume averaged total hemoglobin (HbT), as well as hemoglobin oxygen saturation (SO2) in the tumor vs. surrounding tissues were compared. Outcome prediction metrics based on the differential behavior in tumor vs. normal areas for responders (>50% reduction in maximum diameter) vs. non-responders were analyzed for statistical significance. At baseline, all patients exhibit an initial decrease followed by delayed recovery in HbT, and SO2 in the tumor area, in contrast to almost immediate recovery in surrounding tissue. At day 7 and 30, this contrast is maintained in non-responders; however, in responders, the contrast in hemodynamic time-courses between tumor and normal tissue starts decreasing at day 7 and substantially disappears at day 30. At day 30 into NACT, responding tumors demonstrate “normalization” of compression induced hemodynamics vs. surrounding normal tissue whereas non-responding tumors did not. This data suggests that DTOBI imaging biomarkers, which are governed by the interplay between tissue biomechanics and oxygen metabolism, may be suitable for guiding NACT by offering early predictions of treatment outcome.

© 2017 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system

Stefan A. Carp, Amir Y. Sajjadi, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Steven J. Isakoff
Biomed. Opt. Express 4(12) 2911-2924 (2013)

Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy

David R. Busch, Regine Choe, Mark A. Rosen, Wensheng Guo, Turgut Durduran, Michael D. Feldman, Carolyn Mies, Brian J. Czerniecki, Julia Tchou, Angela DeMichele, Mitchell D. Schnall, and Arjun G. Yodh
Biomed. Opt. Express 4(1) 105-121 (2013)

Pre-clinical longitudinal monitoring of hemodynamic response to anti-vascular chemotherapy by hybrid diffuse optics

Parisa Farzam, Johannes Johansson, Miguel Mireles, Gabriela Jiménez-Valerio, Mar Martínez-Lozano, Regine Choe, Oriol Casanovas, and Turgut Durduran
Biomed. Opt. Express 8(5) 2563-2582 (2017)

References

  • View by:
  • |
  • |
  • |

  1. GLOBOCAN2008, “Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008” (International Agency for Research on Cancer), retrieved October 1, 2013, http://globocan.iarc.fr/ .
  2. N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
    [Crossref] [PubMed]
  3. D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
    [Crossref] [PubMed]
  4. ACS, “National Cancer Data Base Benchmark Reports,” in http://www.facs.org/cancer/ncdb/publicaccess.html , (American College of Surgeons, 2013).
  5. S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
    [Crossref] [PubMed]
  6. N. Wolmark, J. Wang, E. Mamounas, J. Bryant, and B. Fisher, “Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18,” Journal of the National Cancer Institute. Monographs, 96–102 (2001).
    [Crossref]
  7. J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
    [Crossref] [PubMed]
  8. P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
    [Crossref] [PubMed]
  9. J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
    [PubMed]
  10. C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
    [Crossref] [PubMed]
  11. V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
    [Crossref] [PubMed]
  12. P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
    [Crossref] [PubMed]
  13. G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
    [Crossref] [PubMed]
  14. E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
    [Crossref] [PubMed]
  15. A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
    [Crossref] [PubMed]
  16. K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
    [PubMed]
  17. A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
    [Crossref] [PubMed]
  18. O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
    [Crossref] [PubMed]
  19. A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
    [Crossref] [PubMed]
  20. J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
    [Crossref] [PubMed]
  21. Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
    [Crossref] [PubMed]
  22. H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
    [Crossref] [PubMed]
  23. U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
    [Crossref] [PubMed]
  24. M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
    [Crossref] [PubMed]
  25. G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
    [Crossref] [PubMed]
  26. M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
    [Crossref] [PubMed]
  27. P. J. Bolan, “Magnetic resonance spectroscopy of the breast: current status,” Magn. Reson. Imaging Clin. N. Am. 21(3), 625–639 (2013).
    [Crossref] [PubMed]
  28. R. Choe and T. Durduran, “Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy,” IEEE J. Sel. Top. Quantum Electron. 18(4), 1367–1386 (2012).
    [Crossref] [PubMed]
  29. F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
    [Crossref] [PubMed]
  30. S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
    [Crossref] [PubMed]
  31. A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
    [Crossref] [PubMed]
  32. D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
    [Crossref] [PubMed]
  33. Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
    [Crossref] [PubMed]
  34. O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
    [Crossref] [PubMed]
  35. S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
    [Crossref] [PubMed]
  36. M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
    [Crossref] [PubMed]
  37. S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
    [Crossref] [PubMed]
  38. D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
    [Crossref] [PubMed]
  39. R. Al Abdi, H. L. Graber, Y. Xu, and R. L. Barbour, “Optomechanical imaging system for breast cancer detection,” J. Opt. Soc. Am. A 28(12), 2473–2493 (2011).
    [Crossref]
  40. M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
    [Crossref] [PubMed]
  41. S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
    [Crossref] [PubMed]
  42. S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
    [Crossref] [PubMed]
  43. R. X. Xu, B. Qiang, J. J. Mao, and S. P. Povoski, “Development of a handheld near-infrared imager for dynamic characterization of in vivo biological tissue systems,” Appl. Opt. 46(30), 7442–7451 (2007).
    [Crossref] [PubMed]
  44. S. A. Carp, A. Y. Sajjadi, C. M. Wanyo, Q. Fang, M. C. Specht, L. Schapira, B. Moy, A. Bardia, D. A. Boas, and S. J. Isakoff, “Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system,” Biomed. Opt. Express 4(12), 2911–2924 (2013).
    [Crossref] [PubMed]
  45. L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
    [Crossref] [PubMed]
  46. G. J. Zhang, “DOBI Comfortscan System Clinical Effectiveness Evaluation Report” (DOBI Medical International, 2011), retrieved 11/4, 2016, http://dobiglobal.com/pdfs/DOBIComfortScan_Clinical_Report_2011.pdf .
  47. S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
    [Crossref] [PubMed]
  48. S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
    [Crossref] [PubMed]
  49. E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
    [Crossref] [PubMed]
  50. A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
    [Crossref] [PubMed]
  51. Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
    [Crossref] [PubMed]
  52. M. Sridhar and M. F. Insana, “Ultrasonic measurements of breast viscoelasticity,” Med. Phys. 34(12), 4757–4767 (2007).
    [Crossref] [PubMed]
  53. M. Sridhar, C. Pellot-Barakat, and M. F. Insana, “Ultrasonic Mechanical Relaxation imaging,” in 2003 Ieee Ultrasonics Symposium Proceedings,Vols 1 and 2, D. E. Yuhas and S. C. Schneider, eds. (2003), pp. 929–932.
    [Crossref]
  54. P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nat. Rev. Drug Discov. 10(6), 417–427 (2011).
    [Crossref] [PubMed]
  55. A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
    [Crossref] [PubMed]
  56. R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science 307(5706), 58–62 (2005).
    [Crossref] [PubMed]
  57. O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
    [Crossref] [PubMed]

2014 (2)

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

2013 (9)

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

P. J. Bolan, “Magnetic resonance spectroscopy of the breast: current status,” Magn. Reson. Imaging Clin. N. Am. 21(3), 625–639 (2013).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
[Crossref] [PubMed]

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

S. A. Carp, A. Y. Sajjadi, C. M. Wanyo, Q. Fang, M. C. Specht, L. Schapira, B. Moy, A. Bardia, D. A. Boas, and S. J. Isakoff, “Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system,” Biomed. Opt. Express 4(12), 2911–2924 (2013).
[Crossref] [PubMed]

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

2012 (4)

R. Choe and T. Durduran, “Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy,” IEEE J. Sel. Top. Quantum Electron. 18(4), 1367–1386 (2012).
[Crossref] [PubMed]

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

2011 (5)

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

R. Al Abdi, H. L. Graber, Y. Xu, and R. L. Barbour, “Optomechanical imaging system for breast cancer detection,” J. Opt. Soc. Am. A 28(12), 2473–2493 (2011).
[Crossref]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nat. Rev. Drug Discov. 10(6), 417–427 (2011).
[Crossref] [PubMed]

2010 (2)

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

2009 (6)

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

2008 (5)

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

2007 (6)

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
[Crossref] [PubMed]

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

M. Sridhar and M. F. Insana, “Ultrasonic measurements of breast viscoelasticity,” Med. Phys. 34(12), 4757–4767 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

R. X. Xu, B. Qiang, J. J. Mao, and S. P. Povoski, “Development of a handheld near-infrared imager for dynamic characterization of in vivo biological tissue systems,” Appl. Opt. 46(30), 7442–7451 (2007).
[Crossref] [PubMed]

2006 (4)

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

2005 (4)

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science 307(5706), 58–62 (2005).
[Crossref] [PubMed]

2004 (1)

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

2003 (2)

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
[Crossref] [PubMed]

2001 (1)

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

1977 (1)

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

Al Abdi, R.

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

R. Al Abdi, H. L. Graber, Y. Xu, and R. L. Barbour, “Optomechanical imaging system for breast cancer detection,” J. Opt. Soc. Am. A 28(12), 2473–2493 (2011).
[Crossref]

Alvarez, M. C.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

Ancukiewicz, M.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Anderson, S. J.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

André, F.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Arnould, L.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Athanasiou, A.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Avril, N.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Baek, H. M.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Bahri, S.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Baker, W. B.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Balleyguier, C.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Bao, S.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Barbour, R. L.

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

R. Al Abdi, H. L. Graber, Y. Xu, and R. L. Barbour, “Optomechanical imaging system for breast cancer detection,” J. Opt. Soc. Am. A 28(12), 2473–2493 (2011).
[Crossref]

Bardia, A.

Baselga, J.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Batchelor, T. T.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Bear, H. D.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Bergh, J.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Berriolo-Riedinger, A.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Berry, D. A.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Blohmer, J.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Blohmer, J. U.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Blumenthal, G.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Boas, D.

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

Boas, D. A.

Bogaerts, J.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Boichot, C.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Boileau, J. F.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Bolan, P. J.

P. J. Bolan, “Magnetic resonance spectroscopy of the breast: current status,” Magn. Reson. Imaging Clin. N. Am. 21(3), 625–639 (2013).
[Crossref] [PubMed]

Bonnefoi, H.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Boverman, G.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

Braun, M.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Brennan, M.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Brenner, W.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Broglio, K.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Brooks, D. H.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

Brunotte, F.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Buchholz, T.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Busch, D. R.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Butler, J.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Butler, J. A.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Buzdar, A. U.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Byrd, D. R.

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

Cameron, D.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Carmeliet, P.

P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nat. Rev. Drug Discov. 10(6), 417–427 (2011).
[Crossref] [PubMed]

Carp, S. A.

S. A. Carp, A. Y. Sajjadi, C. M. Wanyo, Q. Fang, M. C. Specht, L. Schapira, B. Moy, A. Bardia, D. A. Boas, and S. J. Isakoff, “Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system,” Biomed. Opt. Express 4(12), 2911–2924 (2013).
[Crossref] [PubMed]

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

Carpenter, C. M.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Cerussi, A.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Cerussi, A. E.

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

Chance, B.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Chatterjee, N. A.

N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
[Crossref] [PubMed]

Chen, J. H.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Chen, P. J.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Chen, W. P.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Chia, S.

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

Choe, R.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

R. Choe and T. Durduran, “Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy,” IEEE J. Sel. Top. Quantum Electron. 18(4), 1367–1386 (2012).
[Crossref] [PubMed]

Ciatto, S.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Clarke, L.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Cochet, A.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Cortazar, P.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Costa, A.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Costa, S. D.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Costantino, J. P.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Coudert, B.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Cristofanilli, M.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Cronin, E. B.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Cronin, K. A.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Czarnota, G. J.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Dakhil, S. R.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Danishad, K. K.

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

DeFusco, P. A.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Delorme, S.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Denkert, C.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Dent, R.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Desperito, E.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

di Tomaso, E.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Dietl, J.

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Ditsch, N.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Dromain, C.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Du, J.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Duchateau, L.

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

Duda, D. G.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Durduran, T.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

R. Choe and T. Durduran, “Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy,” IEEE J. Sel. Top. Quantum Electron. 18(4), 1367–1386 (2012).
[Crossref] [PubMed]

Durkin, A.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Eidtmann, H.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Eiermann, W.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

El Khoury, C.

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

Falou, O.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Fang, Q.

S. A. Carp, A. Y. Sajjadi, C. M. Wanyo, Q. Fang, M. C. Specht, L. Schapira, B. Moy, A. Bardia, D. A. Boas, and S. J. Isakoff, “Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system,” Biomed. Opt. Express 4(12), 2911–2924 (2013).
[Crossref] [PubMed]

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

Fasching, P. A.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Feller, A. M.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Fersching, D. M.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Feuer, E. J.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Fink, C.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Fisher, B.

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Flexman, M. L.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

Fong, C. J.

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

Forero, J. A.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Fournier, L. S.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Frazee, T. E.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

Friedman, D. H.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Fryback, D. G.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Fumoleau, P.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Gabka, C. J.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Galetti, K.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Gatzemeier, W.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Georgian-Smith, D.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Gerber, B.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Geyer, C. E.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Gianni, L.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Gibbs, P.

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

Gilbert, F. J.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Gonzalez-Angulo, A. M.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Graber, H. L.

Green, M.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Guarneri, V.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Gunther, J. E.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

Haacke, E. M.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Habbema, J. D.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Halpern, E.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Hamann, U.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Hanusch, C.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Harbeck, N.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Hart, J.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

He, Y.

N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
[Crossref] [PubMed]

Hegde, P. U.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Heinemann, V.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Hennessy, B.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Hershman, D. L.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

Hess, K. R.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Heys, S. D.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Hielscher, A. H.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

Hilfrich, J.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Hoehn, J. L.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Holdenrieder, S.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Hönig, A.

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Hortobagyi, G. N.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Houssami, N.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Hsiang, D.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Hu, J.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Huober, J.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Hutcheon, A. W.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Insana, M. F.

M. Sridhar and M. F. Insana, “Ultrasonic measurements of breast viscoelasticity,” Med. Phys. 34(12), 4757–4767 (2007).
[Crossref] [PubMed]

Intes, X.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Iradji, S.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Irwig, L.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Isakoff, S. J.

Jackisch, C.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Jaenicke, F.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Jagannathan, N. R.

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

Jahedmotlagh, Z.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Jain, R. K.

P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nat. Rev. Drug Discov. 10(6), 417–427 (2011).
[Crossref] [PubMed]

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science 307(5706), 58–62 (2005).
[Crossref] [PubMed]

Jennings, D.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Jermyn, M.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

Jiang, Q.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Jiang, S.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
[Crossref] [PubMed]

Jöbsis, F. F.

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

Julien, J. P.

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

Junkermann, H.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Justice, R.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Kahlenberg, M. S.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Kahlert, S.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Kalinsky, K.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

Kane, M.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Kau, S. W.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Kauffman, T.

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

Kaufman, P. A.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Kaufmann, M.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Keating, N. L.

N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
[Crossref] [PubMed]

Khalil, M. A.

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

Kim, H. K.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

King, K. M.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Klein, S. K.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Knopp, M. V.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Kogel, C.

Kogel, C. A.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Kopans, D.

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

Kopans, D. B.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Kümmel, S.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Kuter, I.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Lahdenranta, J.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Lebeau, A.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Lemon-Wong, S.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Leproux, A.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

Li, J.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Liedtke, C.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Lim, E. A.

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

Loibl, S.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Lowry, M.

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

Macaskill, P.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Mahner, S.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Maidment, A. D.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Mamounas, E.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Mamounas, E. P.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Mandelblatt, J. S.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Mankoff, D. A.

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

Mao, J. J.

Margolese, R. G.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Marinovich, M. L.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Mastanduno, M. A.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

Masuykov, I. V.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Mazouni, C.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

McDermott, G. M.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

McLaren, C.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Mehta, K.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Mehta, R.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Mehta, R. S.

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Mejia, J. A.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Meric, F.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Miao, Y.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Michaelsen, K. E.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

Middleton, L.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

Mieog, J. S.

J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
[Crossref] [PubMed]

Miller, E. L.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

Miller, I. D.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Moore, R.

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Moore, R. H.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

Moy, B.

Moy, L.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Muffly, L. S.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Nagel, D.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Nalcioglu, O.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Nie, K.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Nioka, S.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

O’Sullivan, T. D.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

Ollivier, L.

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

Padhani, A. R.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Paepke, S.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Paik, S.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Pajon, E. R.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Papanicolau, N.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Paulsen, K. D.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
[Crossref] [PubMed]

Pazdur, R.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Perou, C.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Piccart, M.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Pickles, M. D.

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

Pignol, J. P.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Plevritis, S. K.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Pogue, B. W.

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
[Crossref] [PubMed]

Poplack, S. P.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. D. Paulsen, C. Kogel, and S. P. Poplack, “In vivo near-infrared spectral detection of pressure-induced changes in breast tissue,” Opt. Lett. 28(14), 1212–1214 (2003).
[Crossref] [PubMed]

Povoski, S. P.

Prematilake, S.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Prowell, T.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Pusztai, L.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Qiang, B.

Rafferty, E.

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Rakovitch, E.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Rastogi, P.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Ricci, A.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Riedinger, J. M.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Rieger, L.

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Robert, J.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Robidoux, A.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Roblyer, D.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Rosen, M. A.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Sadeghi-Naini, A.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Sajjadi, A. Y.

Salat, C.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Santoro, Y.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

Sardanelli, F.

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Sassen, S.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Schapira, L.

Schnall, M. D.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Schneeweiss, A.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Schwaiger, M.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Schwartz, G. N.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Schwarz-Dose, J.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Schweiger, L.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Seenu, V.

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

Selb, J.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

S. A. Carp, J. Selb, Q. Fang, R. Moore, D. B. Kopans, E. Rafferty, and D. A. Boas, “Dynamic functional and mechanical response of breast tissue to compression,” Opt. Express 16(20), 16064–16078 (2008).
[Crossref] [PubMed]

Semiglazov, V.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Semple, S. I.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Shah, N.

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Shak, S.

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Sharma, U.

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

Siegele, B.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Sigal, R.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Sinn, H. P.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Slaets, L.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Slanetz, P.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Smith, I. C.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Smith, T. A.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Sofroni, E.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

Soliman, H.

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Solomayer, E. F.

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Sorensen, A. G.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Spayne, J.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Specht, M. C.

Sridhar, M.

M. Sridhar and M. F. Insana, “Ultrasonic measurements of breast viscoelasticity,” Med. Phys. 34(12), 4757–4767 (2007).
[Crossref] [PubMed]

Sridhara, R.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Staff, R. T.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Steinkohl, O.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Stoetzer, O. J.

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Su, M. Y.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Sutterlin, M.

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Swain, S. M.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

Symmans, W. F.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Taghian, A.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Tamkus, D.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Tanamai, V. W.

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

Tanamai, W.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Tang, G.

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Tang, S.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Tannenbaum, S. H.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Tardivon, A. A.

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

Tavakoli, B.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Thibault, F.

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

Tiling, R.

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Tordai, A.

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

Toubeau, M.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Touzery, C.

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Tromberg, B.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Tromberg, B. J.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Trudeau, M.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Tubiana-Hulin, M.

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

Turnbull, L. W.

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

Ueda, S.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Untch, M.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

Valagussa, P.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Valero, V.

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

van de Velde, C. J.

J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
[Crossref] [PubMed]

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

van der Hage, J. A.

J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
[Crossref] [PubMed]

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

Vandervelden, C.

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

Vanel, D.

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Vogel, V. G.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

von Minckwitz, G.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Wang, H.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Wang, M.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Wang, X.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Wanyo, C. M.

Wasser, K.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Watson, D.

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Welch, A.

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Wells, W. A.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Wen, P. Y.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Wen, S.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Wickerham, D. L.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

Wolmark, N.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Wright, F. C.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Wright, M. J.

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

Wu, C.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Xu, R. X.

Xu, S.

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

Xu, Y.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

R. Al Abdi, H. L. Graber, Y. Xu, and R. L. Barbour, “Optomechanical imaging system for breast cancer detection,” J. Opt. Soc. Am. A 28(12), 2473–2493 (2011).
[Crossref]

Yaffe, M. J.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Yakovlev, A. Y.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Yeh, E.

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Yeo, P.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Yodh, A. G.

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Yu, H. J.

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Yu, Y.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Zahm, D. M.

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

Zelen, M.

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Zhang, J.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Zhang, L.

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Zhang, Q.

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

Zhang, W. T.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Zhao, Z.

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

Zhong, Y.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Zhu, J.

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

Zhu, Q.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Zubovits, J.

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Zuna, I.

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

Acad. Radiol. (1)

D. R. Busch, R. Choe, T. Durduran, D. H. Friedman, W. B. Baker, A. D. Maidment, M. A. Rosen, M. D. Schnall, and A. G. Yodh, “Blood Flow Reduction in Breast Tissue due to Mammographic Compression,” Acad. Radiol. 21(2), 151–161 (2014).
[Crossref] [PubMed]

Adv. Exp. Med. Biol. (1)

S. Nioka, S. Wen, J. Zhang, J. Du, X. Intes, Z. Zhao, and B. Chance, “Simulation study of breast tissue hemodynamics during pressure perturbation,” Adv. Exp. Med. Biol. 566, 17–22 (2005).
[Crossref] [PubMed]

AJR Am. J. Roentgenol. (1)

E. Yeh, P. Slanetz, D. B. Kopans, E. Rafferty, D. Georgian-Smith, L. Moy, E. Halpern, R. Moore, I. Kuter, and A. Taghian, “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” AJR Am. J. Roentgenol. 184(3), 868–877 (2005).
[Crossref] [PubMed]

Am. J. Public Health (1)

N. A. Chatterjee, Y. He, and N. L. Keating, “Racial Differences in Breast Cancer Stage at Diagnosis in the Mammography Era,” Am. J. Public Health 103(1), 170–176 (2013).
[Crossref] [PubMed]

Appl. Opt. (1)

Biomed. Opt. Express (1)

Br. J. Surg. (1)

J. S. Mieog, J. A. van der Hage, and C. J. van de Velde, “Neoadjuvant chemotherapy for operable breast cancer,” Br. J. Surg. 94(10), 1189–1200 (2007).
[Crossref] [PubMed]

Breast (1)

M. L. Marinovich, F. Sardanelli, S. Ciatto, E. Mamounas, M. Brennan, P. Macaskill, L. Irwig, G. von Minckwitz, and N. Houssami, “Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI,” Breast 21(5), 669–677 (2012).
[Crossref] [PubMed]

Breast Cancer Res. Treat. (1)

G. M. McDermott, A. Welch, R. T. Staff, F. J. Gilbert, L. Schweiger, S. I. Semple, T. A. Smith, A. W. Hutcheon, I. D. Miller, I. C. Smith, and S. D. Heys, “Monitoring primary breast cancer throughout chemotherapy using FDG-PET,” Breast Cancer Res. Treat. 102(1), 75–84 (2007).
[Crossref] [PubMed]

Cancer Lett. (1)

O. J. Stoetzer, D. M. Fersching, C. Salat, O. Steinkohl, C. J. Gabka, U. Hamann, M. Braun, A. M. Feller, V. Heinemann, B. Siegele, D. Nagel, and S. Holdenrieder, “Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin,” Cancer Lett. 336(1), 140–148 (2013).
[Crossref] [PubMed]

Cancer Res. (2)

S. Ueda, D. Roblyer, A. Cerussi, A. Durkin, A. Leproux, Y. Santoro, S. Xu, T. D. O’Sullivan, D. Hsiang, R. Mehta, J. Butler, and B. J. Tromberg, “Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy,” Cancer Res. 72(17), 4318–4328 (2012).
[Crossref] [PubMed]

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo, M. Wang, D. Jennings, P. Y. Wen, J. Lahdenranta, M. Ancukiewicz, E. di Tomaso, D. G. Duda, and R. K. Jain, “A “vascular normalization index” as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients,” Cancer Res. 69(13), 5296–5300 (2009).
[Crossref] [PubMed]

Clin. Breast Cancer (1)

A. Hönig, L. Rieger, M. Sutterlin, J. Dietl, and E. F. Solomayer, “Preoperative chemotherapy and endocrine therapy in patients with breast cancer,” Clin. Breast Cancer 5(3), 198–207 (2004).
[Crossref] [PubMed]

Eur. J. Nucl. Med. Mol. Imaging (1)

A. Berriolo-Riedinger, C. Touzery, J. M. Riedinger, M. Toubeau, B. Coudert, L. Arnould, C. Boichot, A. Cochet, P. Fumoleau, and F. Brunotte, “[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy,” Eur. J. Nucl. Med. Mol. Imaging 34(12), 1915–1924 (2007).
[Crossref] [PubMed]

Eur. J. Radiol. (1)

L. S. Fournier, D. Vanel, A. Athanasiou, W. Gatzemeier, I. V. Masuykov, A. R. Padhani, C. Dromain, K. Galetti, R. Sigal, A. Costa, and C. Balleyguier, “Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels,” Eur. J. Radiol. 69(1), 43–49 (2009).
[Crossref] [PubMed]

Eur. Radiol. (2)

A. A. Tardivon, L. Ollivier, C. El Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” Eur. Radiol. 16(11), 2549–2558 (2006).
[Crossref] [PubMed]

K. Wasser, S. K. Klein, C. Fink, H. Junkermann, H. P. Sinn, I. Zuna, M. V. Knopp, and S. Delorme, “Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution,” Eur. Radiol. 13(1), 80–87 (2003).
[PubMed]

IEEE J. Sel. Top. Quantum Electron. (1)

R. Choe and T. Durduran, “Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy,” IEEE J. Sel. Top. Quantum Electron. 18(4), 1367–1386 (2012).
[Crossref] [PubMed]

IEEE Trans. Med. Imaging (1)

Q. Fang, S. A. Carp, J. Selb, G. Boverman, Q. Zhang, D. B. Kopans, R. H. Moore, E. L. Miller, D. H. Brooks, and D. A. Boas, “Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression,” IEEE Trans. Med. Imaging 28(1), 30–42 (2009).
[Crossref] [PubMed]

J. Biomed. Opt. (4)

S. A. Carp, T. Kauffman, Q. Fang, E. Rafferty, R. Moore, D. Kopans, and D. Boas, “Compression-induced changes in the physiological state of the breast as observed through frequency domain photon migration measurements,” J. Biomed. Opt. 11(6), 064016 (2006).
[Crossref] [PubMed]

M. L. Flexman, M. A. Khalil, R. Al Abdi, H. K. Kim, C. J. Fong, E. Desperito, D. L. Hershman, R. L. Barbour, and A. H. Hielscher, “Digital optical tomography system for dynamic breast imaging,” J. Biomed. Opt. 16(7), 076014 (2011).
[Crossref] [PubMed]

M. L. Flexman, H. K. Kim, J. E. Gunther, E. A. Lim, M. C. Alvarez, E. Desperito, K. Kalinsky, D. L. Hershman, and A. H. Hielscher, “Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography,” J. Biomed. Opt. 18(9), 096012 (2013).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, K. E. Michaelsen, M. Jermyn, M. A. Mastanduno, T. E. Frazee, P. A. Kaufman, and K. D. Paulsen, “Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide,” J. Biomed. Opt. 18(7), 076011 (2013).
[Crossref] [PubMed]

J. Clin. Oncol. (8)

G. von Minckwitz, J. U. Blohmer, S. D. Costa, C. Denkert, H. Eidtmann, W. Eiermann, B. Gerber, C. Hanusch, J. Hilfrich, J. Huober, C. Jackisch, M. Kaufmann, S. Kümmel, S. Paepke, A. Schneeweiss, M. Untch, D. M. Zahm, K. Mehta, and S. Loibl, “Response-Guided Neoadjuvant Chemotherapy for Breast Cancer,” J. Clin. Oncol. 31(29), 3623–3630 (2013).
[Crossref] [PubMed]

J. Schwarz-Dose, M. Untch, R. Tiling, S. Sassen, S. Mahner, S. Kahlert, N. Harbeck, A. Lebeau, W. Brenner, M. Schwaiger, F. Jaenicke, and N. Avril, “Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose,” J. Clin. Oncol. 27(4), 535–541 (2008).
[Crossref] [PubMed]

P. Rastogi, S. J. Anderson, H. D. Bear, C. E. Geyer, M. S. Kahlenberg, A. Robidoux, R. G. Margolese, J. L. Hoehn, V. G. Vogel, S. R. Dakhil, D. Tamkus, K. M. King, E. R. Pajon, M. J. Wright, J. Robert, S. Paik, E. P. Mamounas, and N. Wolmark, “Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27,” J. Clin. Oncol. 26(5), 778–785 (2008).
[Crossref] [PubMed]

J. A. van der Hage, C. J. van de Velde, J. P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau, “Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902,” J. Clin. Oncol. 19(22), 4224–4237 (2001).
[PubMed]

C. Liedtke, C. Mazouni, K. R. Hess, F. André, A. Tordai, J. A. Mejia, W. F. Symmans, A. M. Gonzalez-Angulo, B. Hennessy, M. Green, M. Cristofanilli, G. N. Hortobagyi, and L. Pusztai, “Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer,” J. Clin. Oncol. 26(8), 1275–1281 (2008).
[Crossref] [PubMed]

V. Guarneri, K. Broglio, S. W. Kau, M. Cristofanilli, A. U. Buzdar, V. Valero, T. Buchholz, F. Meric, L. Middleton, G. N. Hortobagyi, and A. M. Gonzalez-Angulo, “Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors,” J. Clin. Oncol. 24(7), 1037–1044 (2006).
[Crossref] [PubMed]

S. Chia, S. M. Swain, D. R. Byrd, and D. A. Mankoff, “Locally advanced and inflammatory breast cancer,” J. Clin. Oncol. 26(5), 786–790 (2008).
[Crossref] [PubMed]

E. P. Mamounas, G. Tang, B. Fisher, S. Paik, S. Shak, J. P. Costantino, D. Watson, C. E. Geyer, D. L. Wickerham, and N. Wolmark, “Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20,” J. Clin. Oncol. 28(10), 1677–1683 (2010).
[Crossref] [PubMed]

J. Opt. Soc. Am. A (1)

Lancet (1)

P. Cortazar, L. Zhang, M. Untch, K. Mehta, J. P. Costantino, N. Wolmark, H. Bonnefoi, D. Cameron, L. Gianni, P. Valagussa, S. M. Swain, T. Prowell, S. Loibl, D. L. Wickerham, J. Bogaerts, J. Baselga, C. Perou, G. Blumenthal, J. Blohmer, E. P. Mamounas, J. Bergh, V. Semiglazov, R. Justice, H. Eidtmann, S. Paik, M. Piccart, R. Sridhara, P. A. Fasching, L. Slaets, S. Tang, B. Gerber, C. E. Geyer, R. Pazdur, N. Ditsch, P. Rastogi, W. Eiermann, and G. von Minckwitz, “Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis,” Lancet 384(9938), 164–172 (2014).
[Crossref] [PubMed]

Magn. Reson. Imaging (1)

M. D. Pickles, P. Gibbs, M. Lowry, and L. W. Turnbull, “Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer,” Magn. Reson. Imaging 24(7), 843–847 (2006).
[Crossref] [PubMed]

Magn. Reson. Imaging Clin. N. Am. (1)

P. J. Bolan, “Magnetic resonance spectroscopy of the breast: current status,” Magn. Reson. Imaging Clin. N. Am. 21(3), 625–639 (2013).
[Crossref] [PubMed]

Med. Phys. (1)

M. Sridhar and M. F. Insana, “Ultrasonic measurements of breast viscoelasticity,” Med. Phys. 34(12), 4757–4767 (2007).
[Crossref] [PubMed]

N. Engl. J. Med. (1)

D. A. Berry, K. A. Cronin, S. K. Plevritis, D. G. Fryback, L. Clarke, M. Zelen, J. S. Mandelblatt, A. Y. Yakovlev, J. D. Habbema, E. J. Feuer, and Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators, “Effect of screening and adjuvant therapy on mortality from breast cancer,” N. Engl. J. Med. 353(17), 1784–1792 (2005).
[Crossref] [PubMed]

Nat. Rev. Drug Discov. (1)

P. Carmeliet and R. K. Jain, “Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases,” Nat. Rev. Drug Discov. 10(6), 417–427 (2011).
[Crossref] [PubMed]

NMR Biomed. (1)

U. Sharma, K. K. Danishad, V. Seenu, and N. R. Jagannathan, “Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy,” NMR Biomed. 22(1), 104–113 (2009).
[Crossref] [PubMed]

Opt. Express (1)

Opt. Lett. (1)

Philos Trans A Math Phys Eng Sci (1)

A. E. Cerussi, V. W. Tanamai, D. Hsiang, J. Butler, R. S. Mehta, and B. J. Tromberg, “Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy,” Philos Trans A Math Phys Eng Sci 369(1955), 4512–4530 (2011).
[Crossref] [PubMed]

Proc. Natl. Acad. Sci. U.S.A. (2)

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W. P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Radiology (4)

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Y. Yu, Q. Jiang, Y. Miao, J. Li, S. Bao, H. Wang, C. Wu, X. Wang, J. Zhu, Y. Zhong, E. M. Haacke, and J. Hu, “Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer,” Radiology 257(1), 47–55 (2010).
[Crossref] [PubMed]

H. M. Baek, J. H. Chen, K. Nie, H. J. Yu, S. Bahri, R. S. Mehta, O. Nalcioglu, and M. Y. Su, “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology 251(3), 653–662 (2009).
[Crossref] [PubMed]

Science (2)

F. F. Jöbsis, “Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters,” Science 198(4323), 1264–1267 (1977).
[Crossref] [PubMed]

R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science 307(5706), 58–62 (2005).
[Crossref] [PubMed]

Transl. Oncol. (2)

O. Falou, A. Sadeghi-Naini, S. Prematilake, E. Sofroni, N. Papanicolau, S. Iradji, Z. Jahedmotlagh, S. Lemon-Wong, J. P. Pignol, E. Rakovitch, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography,” Transl. Oncol. 6(1), 17–24 (2013).
[Crossref] [PubMed]

O. Falou, H. Soliman, A. Sadeghi-Naini, S. Iradji, S. Lemon-Wong, J. Zubovits, J. Spayne, R. Dent, M. Trudeau, J. F. Boileau, F. C. Wright, M. J. Yaffe, and G. J. Czarnota, “Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy,” Transl. Oncol. 5(4), 238–246 (2012).
[Crossref] [PubMed]

Other (5)

GLOBOCAN2008, “Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008” (International Agency for Research on Cancer), retrieved October 1, 2013, http://globocan.iarc.fr/ .

ACS, “National Cancer Data Base Benchmark Reports,” in http://www.facs.org/cancer/ncdb/publicaccess.html , (American College of Surgeons, 2013).

N. Wolmark, J. Wang, E. Mamounas, J. Bryant, and B. Fisher, “Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18,” Journal of the National Cancer Institute. Monographs, 96–102 (2001).
[Crossref]

M. Sridhar, C. Pellot-Barakat, and M. F. Insana, “Ultrasonic Mechanical Relaxation imaging,” in 2003 Ieee Ultrasonics Symposium Proceedings,Vols 1 and 2, D. E. Yuhas and S. C. Schneider, eds. (2003), pp. 929–932.
[Crossref]

G. J. Zhang, “DOBI Comfortscan System Clinical Effectiveness Evaluation Report” (DOBI Medical International, 2011), retrieved 11/4, 2016, http://dobiglobal.com/pdfs/DOBIComfortScan_Clinical_Report_2011.pdf .

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (5)

Fig. 1
Fig. 1 a) DTOBI Instrument mounted on a mobile cart; b) detail of breast compression probe before cart mounting – the CW sources, all FD fibers and the Tekscan mat are mounted on the lower plate, while the upper, mobile plate carries the CW detector fiber bundles and is attached to the translation mechanism through 2 force gauges. c) Schematic of measurement protocol: three compression cycles (about 26 N or 6 lbs), each beginning with FD recording during the compression and for 2 seconds after, followed by a 2 minute CW recording and another 5 second FD acquisition before the compression was released. The cycles were separated by a 90 second no-compression period (the patient’s breast remained in place).
Fig. 2
Fig. 2 a) strain gauge force data for the entire measurement on the tumor breast; blue areas highlight the three main compression periods; b,c) HbT/SO2 variation vs. initial state for the tumor (solid) and normal (dashed) ROIs over the three compression cycles (black, green, red for cycles 1, 2, and 3, respectively)
Fig. 3
Fig. 3 Group averaged compression induced changes in ΔHbT (μM) for responders and non-responders, respectively, within the tumor (red lines) and normal (blue lines) regions of the breast due to compression over the course of NACT (13 subjects for day 0 and day 7, and 7 subjects for day 30). Error bars show standard error.
Fig. 4
Fig. 4 Group averaged compression induced changes in ΔSO2 (μM) for responders and non-responders, respectively, within the tumor (red lines) and normal (blue lines) regions of the breast due to compression over the course of NACT (13 subjects for day 0 and day 7, and 7 subjects for day 30). Error bars show standard error.
Fig. 5
Fig. 5 Receiver Operating Characteristic (ROC) curves for predicting whether a patient will be a responder or non-responder based on the differential change in HbT between the tumor and normal areas at day 7, for t = 60 s, cycle 1, t = 60 s, cycle 2 and t = 90 s, cycle 3.

Tables (5)

Tables Icon

Table 1 Patient demographic and treatment data.

Tables Icon

Table 2 P-values of t-test of the ΔHbT and ΔSO2 during compression compared between responders and non-responders. (T = Tumor tissue, N = Normal tissue)

Tables Icon

Table 3 P-values of t-test on the differences in ΔHbT and ΔSO2 during compression between tumor and normal areas in the same breast in responders vs. non-responders across timepoints, compression cycles and treatment points.

Tables Icon

Table 4 Areas under the ROC curve (AUC) for predicting response vs. non-response using ΔHbT and ΔSO2 change thresholds during compression. (T = Tumor tissue, N = Normal tissue). AUC>0.75 highlighted in bold.

Tables Icon

Table 5 Areas under the ROC curve (AUC) for predicting response vs. non-response using the differences in ΔHbT and ΔSO2 during compression between tumor and normal areas in the same breast. AUC>0.75 highlighted in bold.

Metrics